NDC product
equate mucus relief
NDC 79903-327 · WALMART INC.
Key facts
| Product NDC | 79903-327 |
|---|---|
| Proprietary name | equate mucus relief |
| Nonproprietary name | guaifenesin |
| Substances | GUAIFENESIN |
| Dosage form | TABLET, MULTILAYER, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | WALMART INC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA078912 |
| Pharmacologic classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| Marketing start | Mar 31, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: